Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.
WASHINGTON — President Trump began his second term Monday with a sweeping order aimed at reversing dozens of former President ...
Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker ...
Biden’s domestic policy adviser says Trump avoided pledges to overhaul the Affordable Care Act and other health programs — ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
President Biden’s single term in office will be marked by several moments that saw the White House take the spotlight. It ...
Biden spent like no president in history, and, with a sleight of hand, by taking hundreds of billions out of Medicare and ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback